Hemorrhoidex NDC 34666-191

NDC codes

FDA NDC Directory

Product NDC (as listed)34666-191Labeler and product segments. Claims need a package NDC.

Product NDC at billing width34666-0191Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
34666-191-12	34666019112	12 TABLET in 1 CARTON (34666-191-12)Marketed from Mar 1, 2018
34666-191-30	34666019130	30 TABLET in 1 CARTON (34666-191-30)Marketed from Mar 1, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hemorrhoidex
Generic name (nonproprietary): aesculus hipp, collinsonia, hamamelis
Active ingredients: Horse chestnut — 6 [hp_C]/1Collinsonia canadensis root — 6 [hp_C]/1Hamamelis virginiana root bark/stem bark — 6 [hp_C]/1
Dosage form: Tablet
Route: Oral
Labeler: Nartex Laboratorios Homeopaticos SA DE CV
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Mar 1, 2015
Listing expires: Dec 31, 2026
Identifiers: Product ID 34666-191_6639326d-58c8-5ffb-e053-2991aa0ab583SPL ID 6639326d-58c8-5ffb-e053-2991aa0ab583SPL set ID 811388f2-d64a-4062-961a-8a2a6ecc1c29UNII 3C18L6RJAZ, O2630F3XDR, T7S323PKJSUPC 0844827000382

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N434666019112 followed by a unit qualifier and the quantity

Package 34666-0191-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 27, 2018.

Indications (excerpt from the label)

Uses Temporarily relieves discomforting symptoms such as itching, burning, and swelling associated with hemorrhoids. Product claims and Uses have not been evaluated by the Food and Drug Administration. This product has not been clinically tested by Nartex Labs USA, Inc.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)